Simon 2005.

Methods	Double‐blind, flexible‐dose, placebo‐controlled study
Participants	60 study participants meeting criteria for the A1, A2 and at least 1 additional ASD criterion (i.e., B, C and or D criteria), as determined by the Acute Stress Disorder Interview upon initial evaluation
Interventions	Escitalopram (10 to 40 mg/day) versus placebo x 12 weeks
Outcomes	Primary outcome: symptoms of post‐traumatic stress disorder, symptoms of acute stress disorder Secondary outcome: Clinical Global Improvement
Notes	—

ASD: acute stress disorder
 PTSD: post‐traumatic stress disorder